The athletic performance of thoroughbred racehorses out of mares with suspected placentitis during gestation

Thoroughbred mares treated for signs of placentitis are potentially costly to farms and owners. Although these treatments often are effective, the resulting foal may require expensive aftercare. The current study investigated the future racing performance of foals from mares treated for clinical and subclinical signs of placentitis compared with matched control mares that had no signs of placentitis producing foals on the same farms. In total, 190 horses born from mares with suspected placentitis met the criteria for analysis and were matched with 190 horses born on the same farm. Mare data and percentage of stakes winners in each group were analyzed with Student t test. Analysis between pairs of horses was done using a paired t test for number of starts, wins, places, shows, and amount earned. Significance was set at a P value of <.05. Mares with suspected placentitis were slightly older than control mares, had slightly shorter lengths of gestation, and had a longer interval to subsequent pregnancy than control mares (P < .05). Horses out of suspected placentitis mares that were racing as 2 year olds in the study had no difference in starts, wins, places, shows, and percentages of black-type race winners; however, this group earned more than their matched control pairs (P < .05). Older horses (3 year olds) out of suspected placentitis mares had no differences in number of starts, wins, places, shows or amount earned; however, the matched control older horses had more black-type race winners (P < .05). The information from this study may aid owners when making decisions about treatment options.